Skip to main content

Table 2 Characteristics of identified studies in this meta-analysis

From: Cesarean section to prevent mother-to-child transmission of hepatitis B virus in China: A meta-analysis

   

Study

Newborns

HBV+ newborns

Mothers

Infants

 

Author

Year

Area

design

Caesarean

Vaginal

Caesarean

Vaginal

HBeAg + (%)

Intervention

HBIG

Vaccine

Follow-up

Wang Qingtu

2001

Shandong

RC

38

84

4

28

100

NR

NR

NR

1 h

Wang Jianshe

2002

Shanghai

RC

117

184

13

17

36.54

NR

100%

1, 2 and 7 months

12 months

Wang Lan

2004

Shandong

RC

61

183

11

61

100

NR

75.82%

0, 1 and 6 months

1 month

Wang Yuan

2005

Jiangsu

RC

58

42

1

0

22

100% HBIG

100%

0, 1 and 6 months

2 month

Gu Jie

2006

Ningxia

RC

64

85

2

5

34.9

No

100%

0, 1 and 6 months

12 months

Qian Yanhua

2006

Jiangsu

RC

26

24

0

2

NR

80% HBIG

80%

0, 1 and 6 months

12 months

Fan Yi

2007

Guangdong

RC

92

103

2

9

4.1

NR

100%

0, 1 and 6 months

6 months

Chen Jing1

2007

Tianjin

RC

176

53

27

13

100

NR

NR

NR

1 h

Chen Jing2

2007

Tianjin

RC

112

68

3

10

0

NR

NR

NR

1 h

Li Jijun1

2007

Gansu, Jiangsu

RC

12

49

4

19

100

NR

NR

0, 1 and 6 months

3–9 years

Li Jijun2

2007

Gansu, Jiangsu

RC

74

184

5

28

0

NR

NR

0, 1 and 6 months

3–9 years

Chen Hong

2008

Beijing

RC

112

180

4

5

4.45

No

NR

0, 1 and 6 months

6 months

Liu Xia

2008

Tianjin

RC

153

54

14

15

NR

NR

NR

NR

2 h

Liu Honge

2009

Guangdong

RC

86

123

2

9

3.83

NR

100%

0, 1 and 6 months

1 month

Zhang Qingying

2009

Shanghai

RC

166

52

1

7

NR

No

100%

0, 1 and 6 months

6 months

Zhu Yunxia

2010

Beijing

RC

114

102

5

6

100

No

100%

0, 1 and 6 months

7 months

Yang Peifang

2010

Shanghai

RC

32

36

0

1

19.1

No

100%

0, 1 and 6 months

12 months

Yang Xiaomei

2011

Guangdong

RC

33

49

4

7

NR

NR

100%

0, 1 and 6 months

6 months

Zhang Weili

2011

Shanghai

RC

508

127

17

5

NR

NR

100%

0, 1 and 6 months

3 months

Huang Liu

2012

Guangdong

RC

122

168

9

17

NR

NR

NR

NR

24 h

Guo Zhen

2013

Shanxi

CC

584

549

29

72

36.19

NR

NR

NR

24 h

Wang Ling

2013

Sichuan

RC

112

148

7

16

NR

100% HBIG

100%

0, 1 and 6 months

6 months

Hu Yali

2013

Jiangsu

RC

285

261

7

6

24.73

NR

53.30%

0, 1 and 6 months

5–7 years

Yin Yuzhu

2013

Guangdong

RC

692

668

12

9

34.76

39.70% HBIG

100%

0, 1 and 6 months

12 months

Pan Calvin Q.

2013

Beijing

RC

496

673

7

23

54.5

No

100%

0, 1 and 6 months

7–12 months

Zhang Lei

2014

Multicenter

RC

221

194

17

22

100

21.93% HBIG

84.34%

0, 1 and 6 months

8-12 months

Wang Lina

2014

Guangdong

RC

149

122

6

9

34.32

No

100%

0, 1 and 6 months

7–12 months

Li Weiru

2014

Guangdong

RC

120

120

2

12

NR

No

100%

0, 1 and 6 months

6 months

Huang Dan

2014

Hubei

RC

86

64

4

8

18.67

No

100%

0, 1 and 6 months

6 months

Liu Cuiping

2015

Sichuan

CC

204

52

4

6

67.19

7.81% antiviral; 43.36% HBIG

100%

0, 1 and 6 months

6–12 months and/or 1–3 years